Johnson & Johnson were recently reprimanded in Congress over their Motrin recall in 2009. This year J&J has had to pull over 300 million bottles of top selling brand medicines from American shelves this year, including child brands. The recall came about when the FDA found contaminated ingredients and fifthly equipment at a Pennsylvania factory and then problems with a Puerto Rico Plant. The FDA was told of the Motrin recall in April of 2009, however they did not hear about a recall plan till months later. A unit of J&J did not alert stores and the FDA about the 2009 recall and instead bought back the stock through contractors posing as customers. Although there were no reported injuries due to the product, lawmakers have accused J&J of placing their profits over the welfare of their customers.
It is said that the company is spending $100 million to improve manufacturing and they are trying to get some of their products back on the market. Many store shelves that once held J&J brands, now are empty giving other companies an advantage. J&J’s stock has decreased and experts have said that J&J will have to convince buyers to consume their products once production consumes. As a consumer, it’s frightening to hear that commonly used cold medicines are being recalled because they are being considered unsafe.
This comment has been removed by the author.
ReplyDeleteI find it completely obvious that J&J is placing profits over the welfare of their customers; luckily, this backfired on them. It is important to bring the dishonest actions of such a large company into public view. Not only does it alert consumers of possible health risks, but it will weed out companies who lack morals and/or social responsibility.
ReplyDelete